International Conference on Toxicogenomics and Drug Monitoring August 25-27, 2015 Valencia, Spain

AC has published 12 books and over 530 papers in SCI journals, including papers in Nature, Nature Genetics, Science, PNAS, American Journal of Human Genetics, Gene, European Journal of Human Genetics and specially in Forensic Science journals. Highly cited researcher (Thomson&Reuter 2012) in Molecular Biology and Clinical Medicine. Board member and external adviser of different national and international institutions, foundations and societies on Forensic Science (IALM, MAFS). Past president of the ISFG. Director of 70 Ph.D’s all with the highest qualification and 25 with University or National Awards. Editor of Forensic Science International Genetics and member of the editorial board of a number of the international and national journals on genetics, cancer and forensic science. Prizes and distinctions: Jaime I Award, Adelaide Medal, Galien Medal, Medal Castelao, Medal of Galicia, Medal to the Police merit, Galician Prize of Research, Fernandez Latorre Award, Prismas Award and various prizes from foundations and scientific societies. Doctor Honoris Causa for different universities in Europe and the Americas.

clinical genetics, forensic genetics and genetics of complex traits (particularly sudden cardiac death, cancer, psychiatric diseases and pharmacogenomics)

Antonio Galvez completed his Ph.D at the age of 26 years from University of Granada, and held a postdoctoral position as visiting scientist in Merck, Sharp & Dome. He is the director of the Department of Health Sciences at the University of Jaen. He has published more than 160 papers in reputed journals and serving as an editorial board member of repute.

Microbiology

Mukesh Verma is a Program Director and Chief in the Methods and Technologies Branch (MTB), Epidemiology and Genetics Research Program (EGRP) of the Division of Cancer Control and Population Sciences (DCCPS) at the National Cancer Institute (NCI), National Institutes of Health (NIH). Before coming to the DCCPS, he was a Program Director in the Division of Cancer Prevention (DCP), NCI, providing direction in the areas of biomarkers, early detection, risk assessment and prevention of cancer, and cancers associated with infectious agents. He holds a M.Sc. from Pantnagar University and a Ph.D. from Banaras Hindu University. He did postdoctoral research at George Washington University and was a faculty member at Georgetown University. He has published 136 research articles and reviews and edited three books in cancer epigenetics and epidemiology field.

Toxicogenomics

Professor Shufeng Zhou, MD, PhD, Associate Vice President for Global Medical Development, Associate Dean for International Research, Chair of Department of Pharmaceutical Sciences, College of Pharmacy, Professor of Department of Internal Medicine, Professor of Department of Molecular Medicine, Professor of Department of Molecular Pharmacology & Physiology Morsani College of Medicine, Professor of Moffitt Cancer Center and Research Institute, NCI Cancer Center, Professor of Department of Global Health, College of Public Health

Toxicogenomics

Farhad Kamali is Professor of Human & Experimental Pharmacology at the Institute of Cellular Medicine, Newcastle University, United Kingdom. He has published well over one hundred articles in peer reviewed journals as well as book chapters. Professor Kamali serves on the editorial board of a number of journals in the areas of clinical pharmacology, pharmacogenetics and haematology. Prof Kamali’s research focuses on the elucidation of the mechanisms of drug-induced toxicity and in particular identifying the risk factors associated with poor outcomes in anticoagulation treatment of thromboembolic disease.

Toxicogenomics

Manish Kumar Saraf is a Research Scientist I in Department of Surgery and Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, Texas. He earned a PhD degree from Department of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India and received M.Pharm (Master of Pharmacy) degree in Pharmacology from Department of Pharmaceutical Science and Drug Research, Punjabi University, Patiala, India and B.Pharm (Bachelor of Pharmacy) degree from Department of Pharmaceutical Science, Dr. H. S. Gour, University, Sagar, India. He got a post doc experience from Internal Medicine, UTMB, Galveston and from Neuropharmacology, University of Pompeu Fabara, Barcelona. He has 8 years of pre-doc and more than 4 years of post-doc research experience. He received multiple travel awards from international and national organization (IBRO, SfN, DST, INSA). He has published over 11 research articles in peered reviewed journals and presented his research work in various international and national conferences and scientific meetings (19). He has reviewed many research articles of various reputed journals. He is a member of various scientific societies (Endocrine Society, American Association of Society for Neuroscience, International Brain Research Organization, Indian Pharmacological Society, Neurology Society of India, Indian Science Congress Association, PGI Neurological Society, Indian Academy of Neuroscience.

Severe burn injury produces an overwhelming hypermetabolic stress response affecting all major organs and systems in the body. Elevated level of catecholamine is the important mediators of hypermetabolic response observed in severe burn injury. Currently, he is involved in studying the expression of the adipose tissue lipolytic enzymes and lipid droplet-associated proteins in healthy children and adolescents. He is also currently working on a hypothesis is that Propranolol (non-selective beta-adrenoceptor antagonist) will attenuate the hypermetabolic response, leading to short-term (during acute hospitalization) and long-term (one year post-burn) improvements in lipid and protein metabolism.

Department of Pharmacolgy Vanderbilt University School of Medicine

Toxicogenomics